{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T06:33:35Z","timestamp":1768977215238,"version":"3.49.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Genetics"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.cancergencyto.2010.08.017","type":"journal-article","created":{"date-parts":[[2011,2,8]],"date-time":"2011-02-08T01:37:09Z","timestamp":1297129029000},"page":"39-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Factors influencing a second myeloid malignancy in patients with Philadelphia-negative -7 or del(7q) clones during tyrosine kinase inhibitor therapy for chronic myeloid leukemia"],"prefix":"10.1016","volume":"204","author":[{"given":"Michael J.","family":"Groves","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Sales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norman","family":"Pratt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudhir","family":"Tauro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergencyto.2010.08.017_bib1","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1002\/cncr.24928","article-title":"Optimizing therapy for patients with chronic myelogenous leukemia in chronic phase","volume":"116","author":"Kantarjian","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.cancergencyto.2010.08.017_bib2","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1182\/blood-2007-04-038943","article-title":"How I treat chronic myeloid leukemia in the imatinib era","volume":"110","author":"Goldman","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2010.08.017_bib3","doi-asserted-by":"crossref","first-page":"6041","DOI":"10.1200\/JCO.2009.25.0779","article-title":"Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet","volume":"27","author":"Baccarani","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cancergencyto.2010.08.017_bib4","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1200\/JCO.2009.26.5587","article-title":"Chronic myeloid leukemia: reversing the chronic phase","volume":"28","author":"Goldman","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cancergencyto.2010.08.017_bib5","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1002\/cncr.22936","article-title":"The prognosis for patients with chronic myeloid leukaemia who have clonal cytogenetic abnormalities in Philadelphia chromosome-negative cells","volume":"110","author":"Deininger","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.cancergencyto.2010.08.017_bib6","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/sj.leu.2402848","article-title":"Demonstration of Philadelphia chromosome negative abnormal clones in patients with chronic myelogenous leukemia during major cytogenetic responses induced by imatinib mesylate","volume":"17","author":"O\u2019Dwyer","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2010.08.017_bib7","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/sj.leu.2403399","article-title":"Report of 34 patients with clonal chromosomal abnormalities in Philadelphia-negative cells during imatinib treatment of Philadelphia-positive chronic myeloid leukemia","volume":"18","author":"Terre","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2010.08.017_bib8","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1182\/blood-2007-01-070045","article-title":"Chromosomal abnormalities in Philadelphia chromosome\u2013negative metaphases appearing during imatinib mesylate therapy in patients with newly diagnosed chronic myeloid leukaemia in chronic phase","volume":"110","author":"Jabbour","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2010.08.017_bib9","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.cancergencyto.2006.04.012","article-title":"Philadelphia-negative clonal hematopoiesis following imatinib therapy in patients with chronic myeloid leukaemia: a report of nine cases and analysis of predictive factors","volume":"170","author":"Lin","year":"2006","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2010.08.017_bib10","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/sj.leu.2402791","article-title":"Sustained, clonal karyotype abnormalities in the Philadelphia chromosome negative cells of CML patients successfully treated with imatinib","volume":"17","author":"Meeus","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2010.08.017_bib11","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2141.2004.05215.x","article-title":"Clonal karyotypic abnormalities in Philadelphia negative cells of CML patients treated with imatinib: is it under-reported and does it have any clinical significance?","volume":"127","author":"O\u2019Shea","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2010.08.017_bib12","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1182\/blood-2002-07-2053","article-title":"Emergence of clonal cytogenetic abnormalities in Ph- cellsinsome CML patients in cytogenetic remission to imatinib but restoration of polyclonal hematopoiesis in the majority","volume":"101","author":"Bumm","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2010.08.017_bib13","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1182\/blood-2006-04-017400","article-title":"Myelodysplastic syndromes and acute leukemia developing after imatinib mesylate therapy for chronic myeloid leukemia","volume":"108","author":"Kovitz","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2010.08.017_bib14","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1002\/cncr.22699","article-title":"Characterization of Ph-negative abnormal clones emerging during imatinib therapy","volume":"109","author":"Abruzzese","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.cancergencyto.2010.08.017_bib15","first-page":"e70","article-title":"Clinical significance of development of Philadelphia-chromosome negative clones in patients with chronic myeloid leukemia treated with imatinib mesylate","volume":"90","author":"Perel","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.cancergencyto.2010.08.017_bib16","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/sj.leu.2403345","article-title":"Novel chromosomal aberrations in Philadelphia negative cells of chronic myelogenous leukemia patients on imatinib: report of three cases","volume":"18","author":"Athanasiadou","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2010.08.017_bib17","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/sj.leu.2403361","article-title":"Clonal chromosomal abnormalities in the Philadelphia chromosome negative cells of chronic myeloid leukaemia patients treated with imatinib","volume":"18","author":"Guilbert-Douet","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2010.08.017_bib18","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/sj.leu.2402634","article-title":"Clonal Ph-negative hematopoiesis in CML after therapy with imatinib mesylate is frequently characterized by trisomy 8","volume":"16","author":"Andersen","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2010.08.017_bib19","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/sj.leu.2403607","article-title":"Clonal aberrations in Philadelphia chromosome negative hematopoiesis in patients with chronic myeloid leukemia treated with imatinib or interferon alpha","volume":"19","author":"Bacher","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2010.08.017_bib20","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/cncr.11729","article-title":"Chromosomal abnormalities in Philadelphia chromosome-negative metaphases appearing during imatinib mesylate therapy in patients with Philadelphia chromosome- positive chronic myelogenous leukemia in chronic phase","volume":"98","author":"Medina","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.cancergencyto.2010.08.017_bib21","first-page":"e11","article-title":"Chromosomal abnormalities in Philadelphia (Ph)-negative cells of patients with chronic myeloide leukemia treated with Imatinib (ST1571)","volume":"88","author":"Besalduch","year":"2003","journal-title":"Haematologica"},{"key":"10.1016\/j.cancergencyto.2010.08.017_bib22","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0165-4608(03)00198-5","article-title":"Clonal chromosome aberrations in Philadelphia-negative cells from chronic myelocytic leukemia patients treated with imatinib mesylate: report of two cases","volume":"147","author":"Herens","year":"2003","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2010.08.017_bib23","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1182\/blood-2003-06-1943","article-title":"Chromosomal abnormalities in Ph- cells of patients on imatinib","volume":"102","author":"McMullin","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2010.08.017_bib24","first-page":"556","article-title":"Clonal cytogenetic abnormalities in patients with chronic myeloid leukemia in complete cytogenetic response to imatinib mesylate","volume":"90","author":"Espinet","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.cancergencyto.2010.08.017_bib25","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/ajh.20859","article-title":"Monosomy 7 with severe myelodysplaia developing during imatinib treatment of Philadelphia-positive chronic myeloid leukaemia","volume":"82","author":"Navarro","year":"2007","journal-title":"Am J Hematol"},{"key":"10.1016\/j.cancergencyto.2010.08.017_bib26","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1080\/10428190701297360","article-title":"Philadelphia-negative secondary acute myeloid leukaemia during imatinib treatment for chronic phase chronic myeloid leukaemia","volume":"48","author":"Ross","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.cancergencyto.2010.08.017_bib27","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cancergencyto.2006.12.011","article-title":"Monosomy 7 in t(9;22)- negative cells during nilotinib therapy in an imatinib-resistant chronic myeloid leukemia case","volume":"176","author":"Zeidan","year":"2007","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2010.08.017_bib28","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s12185-008-0224-y","article-title":"Emergence of abnormal clone with monosomy 7 in Philadelphia negative cells of CML patients treated with tyrosine kinase inhibitors","volume":"89","author":"Conchon","year":"2009","journal-title":"Int J Haematol"},{"key":"10.1016\/j.cancergencyto.2010.08.017_bib29","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1600-0609.2009.01335.x","article-title":"Hyperleukocytotic secondary acute myeloid leukemia (AML) with sole monosomy 7 as sequela of Philadelphia-chromosome positive chronic myeloid leukemia (CML)","volume":"83","author":"Hackanson","year":"2009","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.cancergencyto.2010.08.017_bib30","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cancergencyto.2010.02.005","article-title":"Genetic analysis of dasatinib-treated chronic myeloid leukemia rapidly developing into acute myeloid leukemia with monosomy 7 in Philadelphia-negative cells","volume":"199","author":"Larsson","year":"2010","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2010.08.017_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V53.1.1.1","article-title":"Chronic myeloid leukemia with permanent disappearance of the Ph1 chromosome and development of new clonal subpopulations","volume":"53","author":"Hagemeijer","year":"1979","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2010.08.017_bib32","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/sj.leu.2400642","article-title":"Emergence of new clonal abnormalities following interferon-alpha induced complete cytogenetic response in patients with chronic myeloid leukemia: report of three cases","volume":"11","author":"Fayad","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2010.08.017_bib33","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/0165-4608(94)00197-9","article-title":"Clonal origin of Philadelphia chromosome negative cells with trisomy 8 appearing during the course of alpha-interferon therapy for Ph positive chronic myelocytic leukemia","volume":"81","author":"Ariyama","year":"1995","journal-title":"Cancer Genet Cytogenet"}],"container-title":["Cancer Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460810004802?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460810004802?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T15:32:02Z","timestamp":1759073522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165460810004802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0165460810004802"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergencyto.2010.08.017","relation":{},"ISSN":["2210-7762"],"issn-type":[{"value":"2210-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors influencing a second myeloid malignancy in patients with Philadelphia-negative -7 or del(7q) clones during tyrosine kinase inhibitor therapy for chronic myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Cancer Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cancergencyto.2010.08.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}